Page last updated: 2024-09-03

ly 274614 and midazolam

ly 274614 has been researched along with midazolam in 1 studies

Compound Research Comparison

Studies (ly 274614)	Trials (ly 274614)	Recent Studies (post-2010) (ly 274614)	Studies (midazolam)	Trials (midazolam)	Recent Studies (post-2010) (midazolam)
96	0	15	9,834	3,191	3,301

Protein Interaction Comparison

Protein	Taxonomy	ly 274614 (IC50)	midazolam (IC50)
Cytochrome P450 3A4	Homo sapiens (human)		2.7427

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartlett, SE; Cramond, T; Smith, MT	1

Other Studies

1 other study(ies) available for ly 274614 and midazolam

Article	Year
The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life sciences, 1994, Volume: 54, Issue:10 Topics: Akathisia, Drug-Induced; Animals; Behavior, Animal; Binding Sites; Dose-Response Relationship, Drug; Injections, Intraventricular; Isoquinolines; Male; Midazolam; Morphine Derivatives; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Specific Pathogen-Free Organisms	1994

Article

Year

The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.

Life sciences, 1994, Volume: 54, Issue:10

Topics: Akathisia, Drug-Induced; Animals; Behavior, Animal; Binding Sites; Dose-Response Relationship, Drug; Injections, Intraventricular; Isoquinolines; Male; Midazolam; Morphine Derivatives; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Specific Pathogen-Free Organisms

1994